Increasing funding for Myotonic Dystrophy research. Fiscal Year 2024 defense appropriations legislation. Peer Review Medical Research Program and Congressional Directed Medical Research Program.
Federal funding for NIH research.
Duration: November 1, 2019
to
present
General Issues: Medical/Disease Research/Clinical Labs , Budget/Appropriations , Medicare/Medicaid , Defense , Health Issues
Spending: about $30,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2019: U.S. Senate, House of Representatives, Defense - Dept of (DOD), Natl Institutes of Health (NIH)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
John Kevin Brennan Chief of Staff, Rep. Rosa DeLauro (D-CT); Director, Rep. Sherrod Brown (D-OH); Legislative Assistant, Rep. Tom Foglietta (D-PA)
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, BLUEBIRD STRATEGIES lobbied for Myotonic . The report was filed on April 23.
Original Filing: 301576808.xml
Lobbying Issues
Increasing funding for Myotonic Dystrophy research. Fiscal Year 2024 defense appropriations legislation. Peer Review Medical Research Program and Congressional Directed Medical Research Program.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Federal funding for NIH research.
Agencies Lobbied
U.S. Senate
4th Quarter, 2023
In Q4, BLUEBIRD STRATEGIES lobbied for Myotonic . The report was filed on Jan. 5.
Original Filing: 301522003.xml
Lobbying Issues
Increasing funding for Myotonic Dystrophy research. Fiscal Year 2024 defense appropriations legislation. Peer Review Medical Research Program and Congressional Directed Medical Research Program.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Federal funding for NIH research.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2023
In Q3, BLUEBIRD STRATEGIES lobbied for Myotonic . The report was filed on Oct. 19, 2023.
Original Filing: 301506097.xml
Lobbying Issues
Increasing funding for Myotonic Dystrophy research. Fiscal Year 2024 defense appropriations legislation. Peer Review Medical Research Program and Congressional Directed Medical Research Program.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Federal funding for NIH research.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2023
In Q2, BLUEBIRD STRATEGIES lobbied for Myotonic . The report was filed on July 11, 2023.
Original Filing: 301474465.xml
Lobbying Issues
Increasing funding for Myotonic Dystrophy research. Fiscal Year 2024 defense appropriations legislation. Peer Review Medical Research Program and Congressional Directed Medical Research Program.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Federal funding for NIH research.
Agencies Lobbied
U.S. Senate
1st Quarter, 2023
In Q1, BLUEBIRD STRATEGIES lobbied for Myotonic . The report was filed on April 18, 2023.
Original Filing: 301454082.xml
Lobbying Issues
Increasing funding for Myotonic Dystrophy research. Fiscal Year 2024 defense appropriations legislation. Peer Review Medical Research Program and Congressional Directed Medical Research Program.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Federal funding for NIH research.
Agencies Lobbied
U.S. Senate
4th Quarter, 2022
In Q4, BLUEBIRD STRATEGIES lobbied for Myotonic . The report was filed on Jan. 16, 2023.
Original Filing: 301428440.xml
Lobbying Issues
Increasing funding for Myotonic Dystrophy research. Fiscal Year 2023 defense appropriations legislation. Peer Review Medical Research Program and Congressional Directed Medical Research Program.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Federal funding for NIH research.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2022
In Q3, BLUEBIRD STRATEGIES lobbied for Myotonic . The report was filed on Oct. 11, 2022.
Original Filing: 301402422.xml
Lobbying Issues
Increasing funding for Myotonic Dystrophy research. Fiscal Year 2023 defense appropriations legislation. Peer Review Medical Research Program and Congressional Directed Medical Research Program.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Federal funding for NIH research.
Agencies Lobbied
U.S. Senate
Lobbying Issues
S. Res. 772, A resolution designating September 15, 2022, as "International Myotonic Dystrophy Awareness Day" and supporting the goals and ideals of International Myotonic Dystrophy Awareness Day.
2nd Quarter, 2022
In Q2, BLUEBIRD STRATEGIES lobbied for Myotonic . The report was filed on July 12, 2022.
Original Filing: 301379256.xml
Lobbying Issues
Increasing funding for Myotonic Dystrophy research. Fiscal Year 2023 defense appropriations legislation. Peer Review Medical Research Program and Congressional Directed Medical Research Program.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Federal funding for NIH research.
Agencies Lobbied
U.S. Senate
Lobbying Issues
S. Res. 336, A resolution designating September 15, 2021, as "International Myotonic Dystrophy Awareness Day" and supporting the goals and ideals of International Myotonic Dystrophy Awareness Day.
1st Quarter, 2022
In Q1, BLUEBIRD STRATEGIES lobbied for Myotonic . The report was filed on April 18, 2022.
Original Filing: 301359045.xml
Lobbying Issues
Increasing funding for Myotonic Dystrophy research. Fiscal Year 2023 defense appropriations legislation. Peer Review Medical Research Program and Congressional Directed Medical Research Program.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Federal funding for NIH research.
Agencies Lobbied
U.S. Senate
Lobbying Issues
S. Res. 336, A resolution designating September 15, 2021, as "International Myotonic Dystrophy Awareness Day" and supporting the goals and ideals of International Myotonic Dystrophy Awareness Day.
4th Quarter, 2021
In Q4, BLUEBIRD STRATEGIES lobbied for Myotonic . The report was filed on Jan. 18, 2022.
Original Filing: 301325394.xml
Lobbying Issues
Increasing funding for Myotonic Dystrophy research. Fiscal Year 2020 defense appropriations legislation. Peer Review Medical Research Program and Congressional Directed Medical Research Program.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Federal funding for NIH research.
Agencies Lobbied
U.S. Senate
Lobbying Issues
S. Res. 336, A resolution designating September 15, 2021, as "International Myotonic Dystrophy Awareness Day" and supporting the goals and ideals of International Myotonic Dystrophy Awareness Day.
3rd Quarter, 2021
In Q3, BLUEBIRD STRATEGIES lobbied for Myotonic . The report was filed on Oct. 15, 2021.
Original Filing: 301300135.xml
Lobbying Issues
Increasing funding for Myotonic Dystrophy research. Fiscal Year 2020 defense appropriations legislation. Peer Review Medical Research Program and Congressional Directed Medical Research Program. Myotonic Dystrophy resolution.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Federal funding for NIH research.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2021
In Q2, BLUEBIRD STRATEGIES lobbied for Myotonic . The report was filed on July 19, 2021.
Original Filing: 301283007.xml
Lobbying Issues
Increasing funding for Myotonic Dystrophy research. Fiscal Year 2020 defense appropriations legislation. Peer Review Medical Research Program and Congressional Directed Medical Research Program. Myotonic Dystrophy resolution.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Federal funding for NIH research.
Agencies Lobbied
U.S. Senate
1st Quarter, 2021
In Q1, BLUEBIRD STRATEGIES lobbied for Myotonic . The report was filed on April 16, 2021.
Original Filing: 301254840.xml
Lobbying Issues
Increasing funding for Myotonic Dystrophy research. Fiscal year 2020 defense appropriations legislation. Peer Review Medical Research Program and Congressional Directed Medical Research Program.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Federal funding for NIH research.
Agencies Lobbied
U.S. Senate
4th Quarter, 2020
In Q4, BLUEBIRD STRATEGIES lobbied for Myotonic . The report was filed on Jan. 19, 2021.
Original Filing: 301236935.xml
Lobbying Issues
Increasing funding for Myotonic Dystrophy research. Fiscal year 2020 defense appropriations legislation. Peer Review Medical Research Program and Congressional Directed Medical Research Program.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2020
In Q3, BLUEBIRD STRATEGIES lobbied for Myotonic . The report was filed on Oct. 13, 2020.
Original Filing: 301209059.xml
Lobbying Issues
Increasing funding for Myotonic Dystrophy research. Fiscal year 2020 defense appropriations legislation. Peer Review Medical Research Program and Congressional Directed Medical Research Program.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2020
In Q2, BLUEBIRD STRATEGIES lobbied for Myotonic , earning $10,000. The report was filed on July 7, 2020.
Original Filing: 301185744.xml
Lobbying Issues
Increasing funding for Myotonic Dystrophy research. Fiscal year 2020 defense appropriations legislation. Peer Review Medical Research Program and Congressional Directed Medical Research Program.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2020
In Q1, BLUEBIRD STRATEGIES lobbied for Myotonic , earning $10,000. The report was filed on April 14, 2020.
Original Filing: 301166558.xml
Lobbying Issues
Increasing funding for Myotonic Dystrophy research. Fiscal year 2020 defense appropriations legislation. Peer Review Medical Research Program and Congressional Directed Medical Research Program.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2019
In Q4, BLUEBIRD STRATEGIES lobbied for Myotonic , earning $10,000. The report was filed on Jan. 16, 2020.
Original Filing: 301107934.xml
Lobbying Issues
Increasing funding for Myotonic Dystrophy research. Fiscal year 2020 defense appropriations legislation. Peer Review Medical Research Program and Congressional Directed Medical Research Program.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2019
BLUEBIRD STRATEGIES filed a lobbying registration on Dec. 4, 2019 to represent Myotonic, effective Nov. 1, 2019.
Original Filing: 301091929.xml
Issue(s) they said they’d lobby about: Increasing funding for Myotonic Dystrophy research. Fiscal year 2019 defense appropriations legislation. Peer Review Medical Research Program and Congressional Directed Medical Research Program. .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...